Tetra BioPharma Inc (OTCMKTS:TBPMF) recently provided the
management update on its undertakings to promote one of its topical products, Awaye™, and commercialize other
natural health drugs and non-prescription products across the region of North America. Furthermore, Tetra
Bio-Pharma (TNH) is planning to enter into a distribution merger to enhance the
commercialization of its over-the-counter (OTC) pain killer drugs portfolio.

The company intends
to commercialize a portfolio of OTC products that are already at an advanced
stage; hence, no further capital investment or clinical research is necessarily
required. Additionally, Tetra has verified that the development of the two OTC DIN
products is at its final stage. One of the drugs will be used to treat
hemorrhoids while the second one is a pain relief for aches, joints, and muscle
pains ranging from backache, bruises, rheumatic, arthritic, and ligaments.

Market Expansion into Canada and USA

The company further
stated that the non-prescription drug applications are ready for the market,
and plans are underway to submit to Health Canada before the end of the month.
Also, TNH plans to launch the same products into the US market before the end
of 2020. Currently, the company is developing a manufacturing plant and has
applied for the National Drug Code (NDC) from the US Food and Drug
Administration (FDA).

Additional Drug Portfolio

TNH has extra non-prescription drug product line specifically for Canada and US
OTC drug markets. These OTC drugs contain an aspect of beta-caryophyllene and,
therefore, may not require a prior clinical trial to sustain its DIN
application. OTC drugs are used explicitly for self-care therapies.

Other developments
in the company include a strong relationship with Azevedos, one of the oldest
Pharmaceutical companies in Portugal, with operations in Mozambique, Tunisia,
and other regions globally. Further, TNH has invested in state-of-the-art
manufacturing facilities, infrastructure, and human resources. The company’s
focus on natural health products has enabled it to prosper and become famous in
the European markets and worldwide. The company is planning to enter into
partnerships with other natural product firms for commercialization and
distribution of natural health products.